Advances in the molecular understanding of facioscapulohumeral muscular dystrophy
(FSHD) have revealed that FSHD results from epigenetic de-repression of the DUX4 gene in …

Facioscapulohumeral muscular dystrophy (FSHD) is characterised by progressive skeletal
muscle weakness and wasting. FSHD is linked to epigenetic derepression of the …

Facioscapulohumeral muscular dystrophy (FSHD) is characterised by descending skeletal
muscle weakness and wasting. FSHD is caused by mis-expression of the transcription factor …

Whilst a disease-modifying treatment for Facioscapulohumeral muscular dystrophy (FSHD)
does not exist currently, recent advances in complex molecular pathophysiology studies of …

Genetic diagnosis of facioscapulohumeral muscular dystrophy (FSHD) remains a challenge
in clinical practice as it cannot be detected by standard sequencing methods despite being …

Fascioscapulohumeral muscular dystrophy (FSHD) is caused by a unique genetic
mechanism that relies on contraction and hypomethylation of the D4Z4 macrosatellite array …

Facioscapulohumeral muscular dystrophy (FSHD), a common hereditary myopathy, is
caused either by the contraction of the D4Z4 macrosatellite repeat at the distal end of …

Background Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant
muscular disorder characterized by asymmetric muscle wasting and weakness. FSHD can …

Facioscapulohumeral dystrophy (FSHD) has a unique genetic aetiology resulting in partial
chromatin relaxation of the D4Z4 macrosatellite repeat array on 4qter. This D4Z4 chromatin …

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common muscular
dystrophies. Over the last decade, a consensus was reached regarding the underlying …